Ferroptosis in pulmonary fibrosis: an emerging therapeutic target
Frontiers in Physiology · 17.08.2023 · 14
DOI: 10.3389/fphys.2023.1205771 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Physiology, online erschienen am 17.08.2023. Verfasst von Chunyan Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Practice, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, The First Hospital of Jilin Un…. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jilin Province.
Abstract (Originalsprache)
In recent years, the role of ferroptosis in pulmonary fibrosis has garnered increasing interest as a potential therapeutic target. Pulmonary fibrosis is a pathological process characterized by the accumulation of extracellular matrix in affected lung tissues, and currently, there are no effective therapies for preventing or reversing the fibrotic lesions. Ferroptosis is a form of programmed cell death that is regulated by a network of enzymes and signaling pathways. Dysregulation of ferroptosis has been implicated in several diseases, including pulmonary fibrosis. The accumulation of lipid peroxides in the course of ferroptosis causes damage to cell membranes and other cellular components, leading ultimately to cell death. Relevant targets for therapeutic intervention in ferroptosis include key enzymes, such as glutathione peroxidase 4, transcription factors like nuclear factor erythroid 2-related factor 2, and iron chelation. This review provides an overview of the emerging role of ferroptosis in pulmonary fibrosis and highlights potential therapeutic targets in this pathway. Further research is needed to develop safe and effective approaches targeting ferroptosis in treatment of pulmonary fibrosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Practice, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, The First Hospital of Jilin University, Changchun, China.
- Department of Respiratory Medicine, Center for Pathogen Biology and Infectious Diseases, The First Hospital of Jilin University, Changchun, China.
Förderung
- Natural Science Foundation of Jilin Province
Zitieren
APA
Wang, C., Hua, S., & Song, L. (2023). Ferroptosis in pulmonary fibrosis: an emerging therapeutic target. Frontiers in Physiology, 14. https://doi.org/10.3389/fphys.2023.1205771
Vancouver
Wang C, Hua S, Song L. Ferroptosis in pulmonary fibrosis: an emerging therapeutic target. Frontiers in Physiology. 2023;14. doi:10.3389/fphys.2023.1205771
BibTeX
@article{Wang2023,
author = {Wang, Chunyan and Hua, Shucheng and Song, Lei},
title = {Ferroptosis in pulmonary fibrosis: an emerging therapeutic target},
journal = {Frontiers in Physiology},
year = {2023},
volume = {14},
doi = {10.3389/fphys.2023.1205771}
}
EUVIMED